EQS-News: Symrise delivered strong volume-driven organic sales growth in Q3 2026 and reaffirms full-year outlook
Summary by AI BETAClose X
|
EQS-News: Symrise AG
/ Key word(s): 9 Month figures
Press release
Symrise AG, a leading global supplier of flavors and fragrances, as well as cosmetic and functional ingredients, achieved organic sales growth of 5.3% in the third quarter of 2026, exceeding expectations. Growth was predominantly volume-driven, supported by solid customer demand and more favorable year-on-year comparables. Both segments contributed to the strong performance, with Pet Food and Care & Wellness returning to positive organic sales growth. Regional momentum was led by double-digit growth in Asia Pacific, complemented by strong growth in Latin America and solid performance in North America, while Europe, Africa & Middle East recorded moderate growth. Group sales reached €1,310 million in the third quarter, compared with €1,222 million in the prior-year quarter. For the first nine months of 2026, Group sales totaled €3,850 million, compared with €3,776 million in the prior-year period, representing organic sales growth of 3.0%. Dr Jean-Yves Parisot, CEO of Symrise AG, said: “Our strong third quarter performance reflects the positive momentum of our businesses in resilient underlying markets, the strength of our customer relationships and the dedication of our teams. We continue to create and deliver differentiated value to our customers through disciplined execution. We are advancing our strategic priorities by sharpening our portfolio while progressing our ONE SYM Transformation. We have a clear focus on improving operational efficiencies which we reinvest in innovation, commercial excellence and digital capabilities. Together, these actions are strengthening our competitiveness and reinforcing our ability to deliver durable, profitable growth”. Segment sales performance Taste, Nutrition & Health The Taste, Nutrition & Health Segment delivered organic sales growth of 5.2% in the third quarter of 2026. Reported sales increased to €790 million, compared with €736 million in the prior-year quarter.
For the first nine months of 2026, Taste, Nutrition & Health achieved organic sales growth of 3.9%. Reported sales totaled €2,320 million, compared with €2,263 million in the prior-year period. Scent & Care The Scent & Care Segment achieved organic sales growth of 5.6% in the third quarter of 2026. Reported sales increased to €520 million, compared with €487 million in the prior-year quarter.
For the first nine months of 2026, Scent & Care achieved organic sales growth of 1.8%. Reported sales were €1,530 million, compared with €1,513 million in the prior-year period. Share buyback progressing as planned Symrise continued to execute its share buyback program during the third quarter. By the end of September 2026, the company had repurchased 4.3 million shares. The program is scheduled to conclude on October 30, 2026. As previously announced, the repurchased shares are intended to be cancelled following completion of the program. The program forms part of Symrise’s disciplined capital allocation approach and underlines its focus on shareholder value creation. Executing ONE Symrise Strategy and ONE SYM Transformation Symrise continued to advance its ONE Symrise Strategy through proactive portfolio management and targeted investment in growth. The company completed the divestment of its Terpenes business and the acquisition of Floral Concept. Together with the investment in Maison Lautier 1795, Floral Concept strengthens Symrise’s position in Premium Naturals. The company is also investing in organic capacity, including Aroma Molecules. These actions sharpen the portfolio, focus resources on higher-growth, innovation-led businesses and support improved earnings quality. In parallel, the ONE SYM Transformation is moving from organizational redesign to implementation with four priorities: commercial excellence, differentiated innovation, scale benefits and digitalization. By standardizing processes, leveraging its global scale and strengthening execution, the company aims to continue generating efficiencies that can be strategically reinvested in growth opportunities. This approach is designed to enhance customer competitiveness and support durable, profitable, above-market growth. Full-year 2026 outlook Symrise reaffirms its full-year 2026 outlook:
For the full year 2026, Symrise expects organic sales growth near the midpoint of the guidance range. Fourth-quarter growth is expected to moderate sequentially from the Q3 level, against higher prior-year comparables. The adjusted EBITDA margin is expected to be in the lower half of the guidance range, reflecting disciplined reinvestments in IT, innovation and people. The outlook is underpinned by the accelerated execution of the ONE SYM Transformation program, strong project vitality with key customers, a solid pipeline of new solutions and the resilience of the company’s core end markets. About Symrise Symrise is a global supplier of flavors and fragrances, cosmetic base and active ingredients, and functional ingredients. Its customers include manufacturers of perfume, cosmetics, food and beverages, as well as the pharmaceutical industry and producers of dietary supplements and pet food. With sales of around €4.9 billion in the 2025 financial year, the company is one of the world’s leading providers. Headquartered in Holzminden, Germany, the Group has more than 100 sites in Europe, Africa and the Middle East, Asia, North America and Latin America. Together with its customers, Symrise develops new ideas and market-ready concepts for products that have become an indispensable part of everyday life. Economic success and corporate responsibility are inextricably linked. Symrise – always inspiring more...
28.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Symrise AG |
| Mühlenfeldstraße 1 | |
| 37603 Holzminden | |
| Germany | |
| Phone: | +49 (0)5531 90 0 |
| E-mail: | ir@symrise.com |
| Internet: | www.symrise.com |
| ISIN: | DE000SYM9999, DE000SYM7787, DE000SYM7704 |
| WKN: | SYM999 |
| Indices: | DAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX |
| LEI Code: | 529900D82I6R9601CF26 |
| EQS News ID: | 2423280 |
| End of News | EQS News Service |
|
|
2423280 28.10.2026 CET/CEST
Latest directors dealings
- 2 days ago City of London Investment Group
- 2 days ago Aberdeen Group plc
- 2 days ago NATWEST GROUP
- 2 days ago Ondo Insurtech
- 2 days ago Banco Santander S.A.